Related Experiment Video
Updated: May 31, 2026

A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder
Published on: June 18, 2018
Aminorex poisoning in cocaine abusers.
Steven B Karch1, Francesco Mari, Viola Bartolini
1Consultant Pathologist/Toxicologist, Berkeley, California, United States. skarch@fdaa.com
Illicit cocaine often contains levamisole, which the body converts to aminorex. This conversion may lead to a new epidemic of idiopathic pulmonary hypertension (IPH) among drug abusers.
Area of Science:
- Toxicology
- Pharmacology
- Public Health
Background:
- Levamisole is a common adulterant in illicit cocaine.
- Levamisole is metabolized to aminorex in both horses and humans.
- Aminorex was previously linked to an epidemic of idiopathic pulmonary hypertension (IPH).
Purpose of the Study:
- To highlight the potential public health risk of levamisole-induced aminorex conversion.
- To raise awareness of a potential emerging epidemic of IPH in cocaine users.
Main Methods:
- Review of existing literature on levamisole, aminorex, and IPH.
- Analysis of the metabolic pathway of levamisole to aminorex in humans.
- Assessment of the potential for IPH development in chronic cocaine abusers.
Main Results:
- Levamisole, present in over 80% of seized cocaine in the US, converts to aminorex in humans.
- Aminorex caused a fatal IPH epidemic in the past.
- High cocaine intake by abusers may lead to sufficient aminorex formation to cause IPH.
Conclusions:
- The conversion of levamisole to aminorex poses a significant risk for developing IPH.
- Early IPH symptoms are vague, and drug abusers are often excluded from registries, complicating tracking.
- This highlights a potential, underrecognized public health crisis among illicit drug users.
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Toxidromes: Clinical Features
Drug Abuse and Addiction: Pharmacological Phenomena
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs Affecting Neurotransmitter Synthesis
Drugs Affecting Neurotransmitter Release or Uptake

